The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...
Crown Laboratories, Inc. ("Crown"), a privately held, global innovative leader in the skincare industry, today announced the successful closing of its acquisition of Revance Therapeutics, ...
BryteBridge Group ("BryteBridge"), a leading provider of nonprofit organization formation and compliance services, today announced the acquisition of 501c3 Center, MoneyMinder, and Nonprofit Suite.